SFA Therapeutics is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease - the use of microbiome-derived metabolites as drugs.

Biotechnology

Health Care

Therapeutics

SFA Therapeutics

Ira C. Spector

Shawn Patrick O'Brien

Stefan Weiss

Craig Kenesky

Robert Dickey

Alla Arzumanyan

Mark Feitelson

The Advisory Team at SFA Therapeutics provides strategic guidance on both scientific and business aspects of the company. Leveraging their expertise, they assist in navigating the development of microbiome-derived metabolites for chronic inflammatory diseases, ensuring alignment with industry standards and business objectives.

Advisory Team

Leadership Team

Advisory Team

About

Team members

Other teams at SFA Therapeutics

Leadership Team